In 2013, ovarian-cancer advocacy groups created the day to unite in fighting ovarian carcinoma. In the United States, it is estimated that one in 78 women will be diagnosed as having ovarian cancer. Early detection increases the chances of survival. However, even when symptoms are apparent, many women do not receive a diagnosis until advanced stages.
The subtle symptoms can easily be confused with those of other diseases. There is also no early detection test. Currently, no tool is available to screen for ovarian carcinoma, making early diagnosis even more difficult. It is important to spread awareness.
The SROCF strives to close the care gap, and the World Ovarian Cancer Day slogan, "No Woman Left Behind," is a constant theme. The SROCF has launched a new initiative called the 3 to 13 initiative. Black women comprise 13% of US citizens, but they only represent 3% of those participating in ovarian cancer trials. The initiative is designed to reduce disparities among under-represented groups in relation to ovarian carcinoma, remove biases within the enrollment system, raise awareness about clinical trial eligibility for providers, and give these patients access to support services.
